Stoke Therapeutics reported total assets of $406.69M and total liabilities of $54.10M for the quarter ended Sep 2026, up 12.9% year over year. This balance sheet covers 34 quarters of results from Jun 2018 through Sep 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 | Sep2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 144.90M | 84.11M | 67.75M | 113.40M | 113.56M | 190.34M | 192.06M | 189.98M | 191.44M | 178.58M | 193.48M | 150.02M | 127.98M | 274.82M | 101.47M | 83.39M | 84.22M | 155.66M | 110.00M | 107.27M | ||||||||||||||
| Short-term InvestmentsInvestments (Current) | 74.92M | 209.11M | 207.88M | 138.26M | 116.04M | 63.33M | 39.39M | 24.74M | 9.95M | 88.51M | 89.18M | 88.92M | 82.51M | 146.24M | 164.92M | 200.45M | 187.89M | 182.81M | 211.92M | |||||||||||||||
| Cash & Current Investments | 219.81M | 293.22M | 275.63M | 251.66M | 229.60M | 253.67M | 231.45M | 214.72M | 201.39M | 178.58M | 281.98M | 239.20M | 216.90M | 357.32M | 247.71M | 248.31M | 284.67M | 343.55M | 292.82M | 319.19M | ||||||||||||||
| Receivables - NetNet Receivables | 1.67M | 9.25M | 5.94M | 4.45M | 7.20M | 8.60M | ||||||||||||||||||||||||||||
| Receivables | 1.67M | 9.25M | 5.94M | 4.45M | 7.20M | 8.60M | ||||||||||||||||||||||||||||
| Prepaid Assets | 6.94M | 12.29M | 13.18M | 12.55M | 10.93M | 10.19M | 10.95M | 10.94M | 11.32M | 10.72M | 10.35M | 9.84M | 11.12M | 12.69M | 13.69M | 7.75M | 8.74M | 10.12M | 14.69M | 17.60M | ||||||||||||||
| Current Assets | 229.22M | 305.77M | 289.16M | 264.60M | 244.07M | 270.24M | 246.23M | 230.02M | 215.34M | 193.28M | 296.99M | 253.61M | 232.76M | 375.74M | 269.97M | 272.44M | 305.70M | 366.68M | 322.54M | 354.42M | ||||||||||||||
| Non-Current Assets | ||||||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 4.14M | 5.04M | 5.87M | 7.16M | 6.68M | 6.79M | 6.47M | 6.22M | 5.82M | 5.28M | 4.77M | 4.33M | 3.91M | 3.61M | 3.34M | 3.08M | 3.15M | 3.40M | 4.83M | 8.21M | ||||||||||||||
| Long-Term Investments | 29.95M | 29.82M | 22.99M | 107.26M | 80.32M | 106.26M | 67.48M | 61.50M | 39.60M | |||||||||||||||||||||||||
| Other Non-Current Assets | 0.57M | 0.57M | 0.57M | 0.57M | 0.57M | 0.57M | 0.57M | 0.57M | 0.57M | 0.57M | 0.49M | 0.49M | 0.72M | 0.72M | 0.72M | 0.72M | 0.23M | 3.23M | 3.23M | 3.23M | ||||||||||||||
| Non-Current Assets | 9.65M | 10.17M | 12.27M | 13.03M | 12.00M | 11.56M | 10.69M | 9.87M | 13.00M | 11.91M | 10.76M | 39.71M | 38.80M | 31.15M | 114.54M | 87.83M | 112.73M | 76.60M | 71.43M | 52.28M | ||||||||||||||
| Assets | 238.87M | 315.94M | 301.43M | 277.63M | 256.07M | 281.80M | 256.92M | 239.89M | 228.34M | 205.18M | 307.76M | 293.32M | 271.56M | 406.89M | 384.51M | 360.26M | 418.43M | 443.28M | 393.97M | 406.69M | ||||||||||||||
| Liabilities | ||||||||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||||||||
| Accounts Payables | 2.39M | 3.33M | 3.60M | 1.91M | 0.77M | 4.30M | 1.56M | 3.08M | 1.70M | 2.10M | 3.95M | 2.49M | 2.50M | 2.19M | 4.31M | 5.87M | 4.94M | 6.84M | 4.79M | 4.03M | ||||||||||||||
| Payables | 2.39M | 3.33M | 3.60M | 1.91M | 0.77M | 4.30M | 1.56M | 3.08M | 1.70M | 2.10M | 3.95M | 2.49M | 2.50M | 2.19M | 4.31M | 5.87M | 4.94M | 6.84M | 4.79M | 4.03M | ||||||||||||||
| Accumulated Expenses | 14.75M | 11.11M | 13.41M | 14.05M | 15.75M | 13.78M | 12.22M | 13.39M | 13.82M | 12.57M | 14.50M | 15.77M | 18.57M | 24.34M | 25.62M | 30.09M | 41.04M | 23.90M | 28.61M | 38.58M | ||||||||||||||
| Other Accumulated Expenses | 0.54M | 0.52M | 0.75M | 0.43M | 0.51M | 0.51M | 0.70M | 0.47M | 0.86M | 0.98M | 1.04M | 0.60M | 0.75M | 2.07M | 1.75M | 0.80M | 1.06M | 1.50M | 1.62M | 1.75M | ||||||||||||||
| Current Deferred Revenue | 8.47M | 10.63M | 12.84M | 14.88M | 13.45M | 8.06M | 8.74M | 15.31M | 20.92M | 26.05M | 31.61M | 18.99M | 18.16M | 8.75M | 5.76M | 11.90M | 10.07M | 8.52M | 6.36M | |||||||||||||||
| Total Current Liabilities | 17.14M | 22.91M | 27.65M | 28.80M | 31.39M | 31.53M | 21.84M | 25.20M | 30.82M | 35.59M | 44.50M | 49.87M | 40.06M | 44.69M | 38.68M | 41.73M | 57.88M | 40.81M | 41.93M | 48.98M | ||||||||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||||||||||
| Non-Current Deferred Revenue | 49.55M | 45.21M | 41.08M | 36.86M | 34.14M | 43.26M | 40.73M | 33.07M | 25.04M | 16.95M | 8.29M | 10.26M | 9.63M | 8.56M | 6.96M | 6.60M | 5.65M | 4.45M | ||||||||||||||||
| Other Non-Current Liabilities | 3.95M | 3.51M | 4.25M | 3.61M | 2.97M | 2.30M | 1.63M | 0.96M | 4.88M | 4.21M | 3.61M | 3.05M | 2.48M | 1.87M | 1.26M | 1.87M | 1.14M | 0.99M | 0.84M | 0.68M | ||||||||||||||
| Total Non-Current Liabilities | 3.95M | 53.06M | 49.46M | 44.69M | 39.82M | 36.45M | 44.89M | 41.69M | 37.96M | 29.25M | 20.55M | 11.34M | 2.48M | 12.13M | 10.89M | 10.43M | 8.10M | 7.59M | 6.49M | 5.13M | ||||||||||||||
| Total Liabilities | 21.09M | 75.96M | 77.11M | 73.48M | 71.22M | 67.97M | 66.72M | 66.89M | 68.78M | 64.84M | 65.05M | 61.21M | 42.53M | 56.81M | 49.57M | 52.16M | 65.98M | 48.40M | 48.42M | 54.10M | ||||||||||||||
| Shareholder's Equity | ||||||||||||||||||||||||||||||||||
| Common Equity | 217.78M | 239.98M | 224.32M | 204.14M | 184.85M | 213.82M | 190.20M | 173.00M | 159.57M | 140.34M | 242.71M | 232.11M | 229.02M | 350.07M | 334.94M | 308.11M | 352.46M | 394.88M | 345.55M | 352.59M | ||||||||||||||
| Liabilities and Shareholders Equity | 238.87M | 315.94M | 301.43M | 277.63M | 256.07M | 281.80M | 256.92M | 239.89M | 228.34M | 205.18M | 307.76M | 293.32M | 271.56M | 406.89M | 384.51M | 360.26M | 418.43M | 443.28M | 393.97M | 406.69M | ||||||||||||||
| Retained Earnings | -196.08M | -220.73M | -245.38M | -271.50M | -297.15M | -319.70M | -350.35M | -374.89M | -401.85M | -428.22M | -453.92M | -480.35M | -490.83M | -377.95M | -401.43M | -439.78M | -497.72M | -547.72M | -609.34M | -682.98M | ||||||||||||||
| Preferred Shares |
Pull Stoke Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=STOK&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "STOK", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=STOK&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();